Medifast (MED) Tops Q3 EPS by 9c
Tweet
Share
E-mail
Get Alerts MED Hot Sheet
Price: $10.51 +3.04%
EPS Growth %: -295.5%
Financial Fact:
Nonoperating Income (Expense), Total: 58K
Today's EPS Names:
CGEH, NAKA, APOG, More
EPS Growth %: -295.5%
Financial Fact:
Nonoperating Income (Expense), Total: 58K
Today's EPS Names:
CGEH, NAKA, APOG, More
Join SI Premium – FREE
Medifast (NYSE: MED) reported Q3 EPS of ($0.21), $0.09 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $89.4 million versus the consensus estimate of $93.8 million.
For earnings history and earnings-related data on Medifast (MED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gulfport Energy and Mobility Global to join S&P SmallCap 600
- Deutsche Bank Downgrades Synaptics (SYNA) to Hold
- Uranium Royalty Corp. sets shareholder vote on $1.14B Sweetwater deal
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
